{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:37:01Z","timestamp":1770914221662,"version":"3.50.1"},"reference-count":174,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Studies using animal models have shed light into the molecular and cellular basis for the neuropathology observed in patients with Alzheimer\u2019s disease (AD). In particular, the role of the amyloid precursor protein (APP) plays a crucial role in the formation of senile plaques and aging-dependent degeneration. Here, we focus our review on recent findings using the Drosophila AD model to expand our understanding of APP molecular function and interactions, including insights gained from the fly homolog APP-like (APPL). Finally, as there is still no cure for AD, we review some approaches that have shown promising results in ameliorating AD-associated phenotypes, with special attention on the use of nutraceuticals and their molecular effects, as well as interactions with the gut microbiome. Overall, the phenomena described here are of fundamental significance for understanding network development and degeneration. Given the highly conserved nature of fundamental signaling pathways, the insight gained from animal models such as Drosophila melanogaster will likely advance the understanding of the mammalian brain, and thus be relevant to human health.<\/jats:p>","DOI":"10.3390\/ijms22137022","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T10:52:46Z","timestamp":1624963966000},"page":"7022","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Nutraceutical and Probiotic Approaches to Examine Molecular Interactions of the Amyloid Precursor Protein APP in Drosophila Models of Alzheimer\u2019s Disease"],"prefix":"10.3390","volume":"22","author":[{"given":"David","family":"Jalali","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD 21250, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justine Anne","family":"Guevarra","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Towson University, Towson, MD 21252, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luz","family":"Martinez","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD 21250, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily","family":"Hung","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD 21250, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0679-1857","authenticated-orcid":false,"given":"Fernando J","family":"Vonhoff","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD 21250, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer\u2019s disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat. Rev. Dis. Primers."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neuroscience.2020.11.015","article-title":"A Multilevel View of the Development of Alzheimer\u2019s Disease","volume":"457","author":"Avila","year":"2021","journal-title":"Neuroscience"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/M19-3887","article-title":"Benefits and harms of prescription drugs and supplements for treatment of clinical Alzheimer-type dementia: A systematic review and meta-analysis","volume":"172","author":"Fink","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","article-title":"Neuropathologically defined subtypes of Alzheimer\u2019s disease with distinct clinical characteristics: A retrospective study","volume":"10","author":"Murray","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer\u2019s disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer\u2019s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_8","first-page":"229","article-title":"Mise en \u00e9vidence immunologique de la prot\u00e9ine tau au niveau des l\u00e9sions de d\u00e9g\u00e9n\u00e9rescence neurofibrillaire de la maladie d\u2019Alzheimer","volume":"95","author":"Brion","year":"1985","journal-title":"Arch. Biol."},{"key":"ref_9","first-page":"325","article-title":"Neuronal loss in the substantia nigra in patients with Alzheimer\u2019s disease and Parkinson\u2019s disease in relation to extrapyramidal symptoms and dementia","volume":"317","author":"Rinne","year":"1989","journal-title":"Prog. Clin. Biol. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0197-4580(89)90007-9","article-title":"Neurofibrillary degeneration and neuronal loss in alzheimer\u2019s disease","volume":"10","author":"Bondareff","year":"1989","journal-title":"Neurobiol. Aging"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0306-4522(95)90397-P","article-title":"Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer\u2019s disease-related neurofibrillary changes","volume":"64","author":"Ohm","year":"1995","journal-title":"Neuroscience"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuron.2006.09.016","article-title":"A hundred years of Alzheimer\u2019s disease research","volume":"52","author":"Hardy","year":"2006","journal-title":"Neuron"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1017\/S1041610295002134","article-title":"Implicit memory performance of patients with Alzheimer\u2019s disease: A brief review","volume":"7","author":"Jelicic","year":"1995","journal-title":"Int. Psychogeriatr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s004060050101","article-title":"Clinical features of Alzheimer\u2019s disease","volume":"249","author":"Kurz","year":"1999","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2796.2004.01386.x","article-title":"Multiple cognitive deficits during the transition to Alzheimer\u2019s disease","volume":"256","author":"Jones","year":"2004","journal-title":"J. Intern. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1532-5415.1995.tb06235.x","article-title":"When Home Caregiving Ends: A Longitudinal Study of Outcomes for Caregivers of Relatives with Dementia","volume":"43","author":"Gold","year":"1995","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_19","first-page":"17","article-title":"A Novel Approach to Treating Alzheimer\u2019s Disease","volume":"1","author":"Quertinmount","year":"2010","journal-title":"Pharm. Wellness Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3233\/JAD-161134","article-title":"Dementia and Pressure Ulcers: Is There a Close Pathophysiological Interrelation?","volume":"56","author":"Jaul","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer\u2019s disease: Definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimer\u2019s Dement. J. Alzheimer\u2019s Assoc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and Biomarker Changes in Dominantly Inherited Alzheimer\u2019s Disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"226ra30","DOI":"10.1126\/scitranslmed.3007901","article-title":"Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer\u2019s Disease","volume":"6","author":"Fagan","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3233\/JAD-2011-0059","article-title":"Alzheimer\u2019s Prevention Initiative: A Plan to Accelerate the Evaluation of Presymptomatic Treatments","volume":"26","author":"Reiman","year":"2011","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_25","first-page":"1","article-title":"The Alzheimer\u2019s Prevention Initiative Composite Cognitive Test: A practical measure for tracking cognitive decline in preclinical Alzheimer\u2019s disease","volume":"12","author":"Langbaum","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/jnc.14036","article-title":"Is sporadic Alzheimer\u2019s disease a developmental disorder?","volume":"143","author":"Arendt","year":"2017","journal-title":"J. Neurochem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/14737159.2019.1626719","article-title":"Blood-based diagnostics of Alzheimer\u2019s disease","volume":"19","author":"Penner","year":"2019","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_28","first-page":"7","article-title":"Neuropathologic changes in Alzheimer\u2019s disease","volume":"64","author":"Wenk","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.neuroimage.2009.05.037","article-title":"Neural correlates of Alzheimer\u2019s disease and mild cognitive impairment: A systematic and quantitative meta-analysis involving 1351 patients","volume":"47","author":"Schroeter","year":"2009","journal-title":"NeuroImage"},{"key":"ref_30","first-page":"5","article-title":"A systematic review and meta-analysis of (18)F-labeled amyloid imaging in Alzheimer\u2019s disease","volume":"1","author":"Yeo","year":"2015","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2967\/jnumed.120.252411","article-title":"First Tau PET Tracer Approved: Toward Accurate In Vivo Diagnosis of Alzheimer Disease","volume":"61","author":"Barthel","year":"2020","journal-title":"J. Nucl. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Zhang, X., Alshakhshir, N., and Zhao, L. (2021). Glycolytic Metabolism, Brain Resilience, and Alzheimer\u2019s Disease. Front. Neurosci., 15.","DOI":"10.3389\/fnins.2021.662242"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Costantini, L.C., Barr, L.J., Vogel, J.L., and Henderson, S.T. (2008). Hypometabolism as a therapeutic target in Alzheimer\u2019s disease. BMC Neurosci., 9.","DOI":"10.1186\/1471-2202-9-S2-S16"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13195-019-0512-1","article-title":"FDG-PET as an independent biomarker for Alzheimer\u2019s biological diagnosis: A longitudinal study","volume":"11","author":"Ou","year":"2019","journal-title":"Alz Res Therapy."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(80)90884-3","article-title":"Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in alzheimer\u2019s disease","volume":"315","author":"Sims","year":"1980","journal-title":"Lancet"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0047-6374(80)90120-7","article-title":"Glycolytic enzymes from human autoptic brain cortex: Normal aged and demented cases","volume":"14","author":"Iwangoff","year":"1980","journal-title":"Mech. Ageing Dev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-4419-8969-7_8","article-title":"Causes and Consequences of Disturbances of Cerebral Glucose Metabolism in Sporadic Alzheimer Disease: Therapeutic Implications","volume":"541","author":"Hoyer","year":"2004","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/193229680800200619","article-title":"Alzheimer\u2019s Disease is Type 3 Diabetes\u2014Evidence Reviewed","volume":"2","author":"Wands","year":"2008","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41582-020-00437-w","article-title":"Brain organoids shed light on APOE genotype and Alzheimer disease pathology","volume":"17","author":"Fyfe","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3389\/fphar.2020.00396","article-title":"Modeling and Targeting Alzheimer\u2019s Disease With Organoids","volume":"11","author":"Papaspyropoulos","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Venkataraman, L., Fair, S.R., McElroy, C.A., Hester, M.E., and Fu, H. (2020). Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: Focus on Alzheimer\u2019s disease. Stem Cell Rev. Rep., 1\u201322.","DOI":"10.1007\/s12015-020-10068-9"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ca.980080612","article-title":"An English translatio of Alzheimer\u2019s 1907 paper, \u201cUber eine eigenartige Erkankung der Hirnrinde\u201d","volume":"8","author":"Alzheimer","year":"1995","journal-title":"Clin Anat."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: The trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1073\/pnas.85.11.4051","article-title":"Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: Identification as the microtubule-associated protein tau","volume":"85","author":"Goedert","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.biocel.2010.07.016","article-title":"Tau protein: Relevance to Parkinson\u2019s disease","volume":"42","author":"Lei","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/WNL.52.7.1397","article-title":"Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment","volume":"52","author":"Jack","year":"1999","journal-title":"Neurology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Subramanian, J., Savage, J.C., and Tremblay, M.-E. (2020). Synaptic Loss in Alzheimer\u2019s Disease: Mechanistic Insights Provided by Two-Photon in vivo Imaging of Transgenic Mouse Models. Front. Cell. Neurosci., 14.","DOI":"10.3389\/fncel.2020.592607"},{"key":"ref_50","first-page":"720","article-title":"Rapid appearance and local toxicity of amyloid-\u03b2 plaques in a mouse model of Alzheimer\u2019s disease","volume":"451","author":"Prada","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40478-017-0415-y","article-title":"High plasticity of axonal pathology in Alzheimer\u2019s disease mouse models","volume":"5","author":"Rodrigues","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00401-017-1804-9","article-title":"BACE1 inhibition more effectively suppresses initiation than progression of \u03b2-amyloid pathology","volume":"135","author":"Peters","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat. Neurosci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1038\/ncomms6659","article-title":"The role of protein clearance mechanisms in organismal ageing and age-related diseases","volume":"5","author":"Vilchez","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(03)00089-3","article-title":"Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory","volume":"70","author":"Turner","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.bi.58.070189.001443","article-title":"Molecular biology ofAlzheimer\u2019s disease","volume":"58","author":"Beyreuther","year":"1989","journal-title":"Annu. Rev. Biochem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1523\/JNEUROSCI.1450-06.2006","article-title":"Synapse Formation and Function Is Modulated by the Amyloid Precursor Protein","volume":"26","author":"Priller","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1326-1-5","article-title":"The amyloid precursor protein: Beyond amyloid","volume":"1","author":"Zheng","year":"2006","journal-title":"Mol. Neurodegener."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/jnc.12675","article-title":"Insights into the physiological function of the \u03b2-amyloid precursor protein: Beyond Alzheimer\u2019s disease","volume":"129","author":"Dawkins","year":"2014","journal-title":"J. Neurochem."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Li Puma, D.D., Piacentini, R., and Grassi, C. (2021). Does Impairment of Adult Neurogenesis Contribute to Pathophysiology of Alzheimer\u2019s Disease? A Still Open Question. Front. Mol. Neurosci., 13.","DOI":"10.3389\/fnmol.2020.578211"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.bbrc.2007.10.021","article-title":"Amyloid-\u03b2 precursor protein expression and modulation in human embryonic stem cells: A novel role for human chorionic gonadotropin","volume":"364","author":"Porayette","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/ng0993-22","article-title":"Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice","volume":"5","author":"Lamb","year":"1993","journal-title":"Nat. Genet."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.febslet.2013.05.010","article-title":"The amyloid precursor protein: A biochemical enigma in brain development, function and disease","volume":"587","author":"Nalivaeva","year":"2013","journal-title":"FEBS Lett."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Akasaka-Manya, K., and Manya, H. (2020). The Role of APP O-Glycosylation in Alzheimer\u2019s Disease. Biomolecules, 10.","DOI":"10.3390\/biom10111569"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40263-019-00613-7","article-title":"A Close Look at BACE1 Inhibitors for Alzheimer\u2019s Disease Treatment","volume":"33","author":"Das","year":"2019","journal-title":"CNS Drugs"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fnagi.2016.00058","article-title":"G protein-coupled receptors (GPCRs) in Alzheimer\u2019s disease: A focus on BACE1 related GPCRs","volume":"8","author":"Zhao","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.neurobiolaging.2006.06.023","article-title":"Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain","volume":"28","author":"Nistor","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jalz.2014.10.007","article-title":"Down syndrome and Alzheimer\u2019s disease: Common pathways, common goals","volume":"11","author":"Hartley","year":"2015","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2007.05.050","article-title":"Expression of APP pathway mRNAs and proteins in Alzheimer\u2019s disease","volume":"1161","author":"Matsui","year":"2007","journal-title":"Brain Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/nm1295-1291","article-title":"The Swedish mutation causes early-onset Alzheimer\u2019s disease by \u03b2-secretase cleavage within the secretory pathway","volume":"1","author":"Haass","year":"1995","journal-title":"Nat. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"658","DOI":"10.4103\/1673-5374.247469","article-title":"Mutations of beta-amyloid precursor protein alter the consequence of Alzheimer\u2019s disease pathogenesis","volume":"14","author":"Li","year":"2019","journal-title":"Neural. Regen. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nn0901-887","article-title":"The \u2019Arctic\u2019 APP mutation (E693G) causes Alzheimer\u2019s disease by enhanced A\u03b2 protofibril formation","volume":"4","author":"Nilsberth","year":"2001","journal-title":"Nat. Neurosci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1523\/JNEUROSCI.22-05-01858.2002","article-title":"The relationship between A\u03b2 and memory in the Tg2576 mouse model of Alzheimer\u2019s disease","volume":"22","author":"Westerman","year":"2002","journal-title":"J. Neurosci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1518.e1","DOI":"10.1016\/j.neurobiolaging.2012.09.017","article-title":"Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population","volume":"34","author":"Kero","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jamaneurol.2014.2157","article-title":"Rarity of the Alzheimer Disease\u2013Protective APP A673T Variant in the United States","volume":"72","author":"Wang","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"30990","DOI":"10.1074\/jbc.M114.589069","article-title":"Molecular Mechanisms of Alzheimer Disease Protection by the A673T Allele of Amyloid Precursor Protein","volume":"289","author":"Maloney","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-015-0247-6","article-title":"The A673T mutation in the amyloid precursor protein reduces the production of \u03b2-amyloid protein from its \u03b2-carboxyl terminal fragment in cells","volume":"3","author":"Kokawa","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/jnc.15212","article-title":"Alzheimer\u2019s protection effect of A673T mutation may be driven by lower A\u03b2 oligomer binding affinity","volume":"157","author":"Limegrover","year":"2021","journal-title":"J. Neurochem."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Tambini, M.D., Norris, K., and D\u2019Adamio, L. (2020). Opposite changes in APP processing and human A\u03b2 levels in rats carrying either a protective or a pathogenic APP mutation. eLife, 9.","DOI":"10.7554\/eLife.52612"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fnmol.2016.00061","article-title":"Analysis of Amyloid Precursor Protein Function in Drosophila melanogaster","volume":"9","author":"Cassar","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fnmol.2017.00003","article-title":"Role of APP Interactions with Heterotrimeric G Proteins: Physiological Functions and Pathological Consequences","volume":"10","author":"Copenhaver","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fgene.2013.00293","article-title":"A tale of two drug targets: The evolutionary history of BACE1 and BACE2","volume":"4","author":"Southan","year":"2013","journal-title":"Front. Genet."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Wong, Y.Y., Le, P., Elkhatib, W., Piekut, T., and Senatore, A. (2019). Transcriptome profiling of Trichoplax adhaerens highlights its digestive epithelium and a rich set of genes for fast electrogenic and slow neuromodulatory cellular signaling. Res. Sq., in preprint research square.","DOI":"10.21203\/rs.2.14504\/v1"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nm.3935","article-title":"Modeling psychiatric disorders for developing effective treatments","volume":"21","author":"Kaiser","year":"2015","journal-title":"Nat. Med."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Vonhoff, F., Williams, A., Ryglewski, S., and Duch, C. (2012). Drosophila as a Model for MECP2 Gain of Function in Neurons. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0031835"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1242\/dmm.023762","article-title":"Drosophila tools and assays for the study of human diseases","volume":"9","author":"Ugur","year":"2016","journal-title":"Dis. Models Mechanisms"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Bolus, H., Crocker, K., Boekhoff-Falk, G., and Chtarbanova, S. (2020). Modeling Neurodegenerative Disorders in Drosophila melanogaster. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093055"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1523\/JNEUROSCI.10-12-03849.1990","article-title":"Identification, secretion, and neural expression of APPL, a Drosophila protein similar to human amyloid protein precursor","volume":"10","author":"Luo","year":"1990","journal-title":"J. Neurosci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/cr.2011.116","article-title":"APP physiological and pathophysiological functions: Insights from animal models","volume":"22","author":"Guo","year":"2011","journal-title":"Cell Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00221-011-2860-3","article-title":"Analysis of amyloid precursor protein function in Drosophila melanogaster","volume":"217","author":"Poeck","year":"2011","journal-title":"Exp. Brain Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1242\/dev.108712","article-title":"Amyloid precursor protein and neural development","volume":"141","author":"Nicolas","year":"2014","journal-title":"Development"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.nbd.2008.10.014","article-title":"Neurotoxic effects induced by the Drosophila amyloid-\u03b2 peptide suggest a conserved toxic function","volume":"33","author":"Proctor","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"16181","DOI":"10.1523\/JNEUROSCI.0228-12.2012","article-title":"-Secretase Cleavage of the Fly Amyloid Precursor Protein Is Required for Glial Survival","volume":"32","author":"Bolkan","year":"2012","journal-title":"J. Neurosci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0896-6273(92)90024-8","article-title":"Human amyloid precursor protein ameliorates behavioral deficit of flies deleted for appl gene","volume":"9","author":"Luo","year":"1992","journal-title":"Neuron"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.expneurol.2015.05.013","article-title":"Modeling the complex pathology of Alzheimer\u2019s disease in Drosophila","volume":"274","year":"2015","journal-title":"Exp. Neurol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1326-8-35","article-title":"Drosophila melanogaster as a model organism for Alzheimer\u2019s disease","volume":"8","author":"Voigt","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12204-021-2261-0","article-title":"Regulation of Sleep Behavior by Overexpression of Amyloid Precursor Protein in Drosophila Neurons","volume":"26","author":"Li","year":"2021","journal-title":"J. Shanghai Jiaotong Univ."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Cordone, S., Scarpelli, S., Alfonsi, V., De Gennaro, L., and Gorgoni, M. (2021). Sleep-Based Interventions in Alzheimer\u2019s Disease: Promising Approaches from Prevention to Treatment along the Disease Trajectory. Pharmaceuticals., 14.","DOI":"10.3390\/ph14040383"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.nbscr.2016.08.002","article-title":"Sleep in Alzheimer\u2019s disease\u2013beyond amyloid","volume":"2","author":"Holth","year":"2017","journal-title":"Neurobiol. Sleep Circadian Rhythm."},{"key":"ref_101","first-page":"253","article-title":"Unraveling the Neurobiology of Sleep and Sleep Disorders Using Drosophila","volume":"121","author":"Chakravarti","year":"2017","journal-title":"Planar Cell Polarity Dur. Dev."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1534\/genetics.116.189589","article-title":"Sleep and Development in Genetically Tractable Model Organisms","volume":"203","author":"Kayser","year":"2016","journal-title":"Genetics"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.expneurol.2015.06.024","article-title":"Use of Drosophila in the investigation of sleep disorders","volume":"274","author":"Donelson","year":"2015","journal-title":"Exp. Neurol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.celrep.2018.12.025","article-title":"Hyperactive Innate Immunity Causes Degeneration of Dopamine Neurons upon Altering Activity of Cdk5","volume":"26","author":"Shukla","year":"2019","journal-title":"Cell Rep."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1080\/15548627.2019.1596499","article-title":"Reduced autophagy efficiency induces innate immune activation leading to neurodegeneration","volume":"15","author":"Shukla","year":"2019","journal-title":"Autophagy"},{"key":"ref_106","first-page":"365","article-title":"Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer\u2019s disease","volume":"518","author":"Gjoneska","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e13070","DOI":"10.1111\/acel.13070","article-title":"CHIP modulates APP-induced autophagy-dependent pathological symptoms in Drosophila","volume":"19","author":"Zhuang","year":"2019","journal-title":"Aging Cell"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Paul, I., and Ghosh, M.K. (2014). The E3 ligase CHIP: Insights into its structure and regulation. BioMed Res. Int., 918183.","DOI":"10.1155\/2014\/918183"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/01677063.2020.1712597","article-title":"Interactions between amyloid precursor protein-like (APPL) and MAGUK scaffolding proteins contribute to appetitive long-term memory in Drosophila melanogaster","volume":"34","author":"Silva","year":"2020","journal-title":"J. Neurogenet."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1523\/JNEUROSCI.2896-10.2011","article-title":"Drosophila Amyloid Precursor Protein-Like Is Required for Long-Term Memory","volume":"31","author":"Goguel","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fnmol.2016.00142","article-title":"Role of Drosophila Amyloid Precursor Protein in Memory Formation","volume":"9","author":"Preat","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bbr.2007.08.003","article-title":"Amyloid precursor protein knockout mice show age-dependent deficits in passive avoidance learning","volume":"186","author":"Senechal","year":"2008","journal-title":"Behav. Brain Res."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Soldano, A., Okray, Z., Janovsk\u00e1, P., Tmejov\u00e1, K., Reynaud, E., Claeys, A., Yan, J., Atak, Z.K., De Strooper, B., and Dura, J.-M. (2013). The Drosophila Homologue of the Amyloid Precursor Protein Is a Conserved Modulator of Wnt PCP Signaling. PLoS Biol., 11.","DOI":"10.1371\/journal.pbio.1001562"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Marquilly, C., Busto, G.U., Leger, B.S., Boulanger, A., Giniger, E., Walker, J.A., Fradkin, L.G., and Dura, J.-M. (2021). Htt is a repressor of Abl activity required for APP-induced axonal growth. PLoS Genet., 17.","DOI":"10.1371\/journal.pgen.1009287"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Kessissoglou, I.A., Langui, D., Hasan, A., Maral, M., Dutta, S.B., Hiesinger, P.R., and Hassan, B.A. (2020). The Drosophila amyloid precursor protein homologue mediates neuronal survival and neuroglial interactions. PLoS Biol., 18.","DOI":"10.1101\/2020.03.09.983353"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Koike, M.A., Lin, A.J., Pham, J., Nguyen, E., Yeh, J.J., Rahimian, R., Tromberg, B.J., Choi, B., Green, K.N., and LaFerla, F.M. (2012). APP Knockout Mice Experience Acute Mortality as the Result of Ischemia. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0042665"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease","volume":"369","author":"Doody","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_118","first-page":"1","article-title":"Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer\u2019s disease","volume":"11","author":"Egan","year":"2019","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jamaneurol.2020.4857","article-title":"Findings of efficacy, safety, and biomarker outcomes of atabecestat in preclinical Alzheimer disease: A truncated randomized phase 2b\/3 clinical trial","volume":"78","author":"Sperling","year":"2021","journal-title":"JAMA Neurol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.2174\/1381612826666200211121416","article-title":"A Chronological Review of Potential Disease-Modifying Therapeutic Strategies for Alzheimer\u2019s Disease","volume":"26","author":"Ettcheto","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.3233\/JAD-201106","article-title":"Pharmacological Strategies to Improve Dendritic Spines in Alzheimer\u2019s Disease","volume":"82","author":"Ettcheto","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Cheng, X., Song, C., Du, Y., Gaur, U., and Yang, M. (2020). Pharmacological Treatment of Alzheimer\u2019s Disease: Insights from Drosophila melanogaster. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21134621"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s13596-019-00393-x","article-title":"Gallic acid protects against neurochemical alterations in transgenic Drosophila model of Alzheimer\u2019s disease","volume":"20","author":"Ogunsuyi","year":"2020","journal-title":"Adv. Tradit. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"97","DOI":"10.15412\/J.BCN.03070203","article-title":"Effect of Gallic Acid on Dementia Type of Alzheimer Disease in Rats: Electrophysiological and Histological Studies","volume":"7","author":"Hajipour","year":"2016","journal-title":"Basic Clin. Neurosci. J."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"16251","DOI":"10.1074\/jbc.RA119.012330","article-title":"Gallic acid is a dual \u03b1\/\u03b2-secretase modulator that reverses cognitive impairment and remediates pathology in Alzheimer mice","volume":"295","author":"Mori","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_126","first-page":"1934578","article-title":"A Role of Gallic Acid in Oxidative Damage Diseases: A Comprehensive Review","volume":"14","author":"Gao","year":"2019","journal-title":"Nat. Prod. Commun."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Suttisansanee, U., Charoenkiatkul, S., Jongruaysup, B., Tabtimsri, S., Siriwan, D., and Temviriyanukul, P. (2020). Mulberry fruit cultivar \u2018Chiang Mai\u2019prevents beta-amyloid toxicity in PC12 neuronal cells and in a Drosophila model of Alzheimer\u2019s disease. Molecules, 25.","DOI":"10.3390\/molecules25081837"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.phytochem.2007.02.004","article-title":"Anthocyanins from red cabbage \u2013 stability to simulated gastrointestinal digestion","volume":"68","author":"McDougall","year":"2007","journal-title":"Phytochemistry"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jnutbio.2009.03.008","article-title":"Antioxidant and cognitive promotion effects of anthocyanin-rich mulberry (Morus atropurpurea L.) on senescence-accelerated mice and prevention of Alzheimer\u2019s disease","volume":"21","author":"Shih","year":"2010","journal-title":"J. Nutr. Biochem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.foodchem.2016.04.133","article-title":"Gallic acid as a protective antioxidant against anthocyanin degradation and color loss in vitamin-C fortified cranberry juice","volume":"210","author":"Roidoung","year":"2016","journal-title":"Food Chem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"22815","DOI":"10.1038\/srep22815","article-title":"Determination of cyanidin 3-glucoside in rat brain, liver and kidneys by UPLC\/MS-MS and its application to a short-term pharmacokinetic study","volume":"6","author":"Fornasaro","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_132","first-page":"180","article-title":"Blood brain barrier permeability of (\u2212)-epigallocatechin gallate, its proliferation-enhancing activity of human neuroblastoma SH-SY5Y cells, and its preventive effect on age-related cognitive dysfunction in mice","volume":"9","author":"Pervin","year":"2017","journal-title":"Biochem. Biophys. Rep."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Thelen, M., and Brown-Borg, H.M. (2020). Does Diet Have a Role in the Treatment of Alzheimer\u2019s Disease?. Front. Aging Neurosci., 12.","DOI":"10.3389\/fnagi.2020.617071"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Gruendler, R., Hippe, B., Jengic, V.S., Peterlin, B., and Haslberger, A.G. (2020). Nutraceutical Approaches of Autophagy and Neuroinflammation in Alzheimer\u2019s Disease: A Systematic Review. Molecules, 25.","DOI":"10.3390\/molecules25246018"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Frydman-Marom, A., Levin, A., Farfara, D., Benromano, T., Scherzer-Attali, R., Peled, S., Vassar, R., Segal, D., Gazit, E., and Frenkel, D. (2011). Orally administrated cinnamon extract reduces \u03b2-amyloid oligomerization and corrects cognitive impairment in Alzheimer\u2019s disease animal models. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016564"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/3570830","article-title":"Cinnamaldehyde Improves Lifespan and Healthspan in Drosophila melanogaster Models for Alzheimer\u2019s Disease","volume":"2018","author":"Pham","year":"2018","journal-title":"BioMed Res. Int."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.phrs.2017.12.011","article-title":"Cinnamon, a promising prospect towards Alzheimer\u2019s disease","volume":"130","author":"Momtaz","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1021\/acschemneuro.0c00232","article-title":"Trehalose Conjugates of Silybin as Prodrugs for Targeting Toxic A\u03b2 Aggregates","volume":"11","author":"Ahmed","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1021\/acschemneuro.7b00110","article-title":"Inhibition of A\u03b2 Amyloid Growth and Toxicity by Silybins: The Crucial Role of Stereochemistry","volume":"8","author":"Sciacca","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Shabbir, U., Rubab, M., Tyagi, A., and Oh, D.-H. (2020). Curcumin and Its Derivatives as Theranostic Agents in Alzheimer\u2019s Disease: The Implication of Nanotechnology. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010196"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"110995","DOI":"10.1016\/j.biopha.2020.110995","article-title":"Association between chronic stress and Alzheimer\u2019s disease: Therapeutic effects of Saffron","volume":"133","author":"Saeedi","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Kim, J. (2021). Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer\u2019s Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22062929"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0047-6374(85)90020-X","article-title":"Iron accumulation during development and ageing of Drosophila","volume":"29","author":"Massie","year":"1985","journal-title":"Mech. Ageing Dev."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3389\/fnins.2018.00533","article-title":"Dysregulation of Neuronal Iron Homeostasis as an Alternative Unifying Effect of Mutations Causing Familial Alzheimer\u2019s Disease","volume":"12","author":"Lumsden","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"113035","DOI":"10.1016\/j.bios.2021.113035","article-title":"Electrochemical biosensors for biometal-protein interactions in neurodegenerative diseases","volume":"179","author":"Li","year":"2021","journal-title":"Biosens. Bioelectron."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/em.22262","article-title":"Toxic and Genotoxic Effects of Silver Nanoparticles in Drosophila","volume":"60","author":"Alaraby","year":"2019","journal-title":"Environ. Mol. Mutagen."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Greish, K., Alqahtani, A.A., Alotaibi, A.F., Abdulla, A.M., Bukelly, A.T., Alsobyani, F.M., Alharbi, G.H., Alkiyumi, I.S., Aldawish, M.M., and Alshahrani, T.F. (2019). The Effect of Silver Nanoparticles on Learning, Memory and Social Interaction in BALB\/C Mice. Int. J. Environ. Res. Public Health, 16.","DOI":"10.3390\/ijerph16010148"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"42871","DOI":"10.1038\/srep42871","article-title":"Silver nanoparticles reduce brain inflammation and related neurotoxicity through induction of H2S-synthesizing enzymes","volume":"7","author":"Leo","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Carranza-Naval, M.J., Vargas-Soria, M., Hierro-Bujalance, C., Baena-Nieto, G., Garcia-Alloza, M., Infante-Garcia, C., and del Marco, A. (2021). Alzheimer\u2019s Disease and Diabetes: Role of Diet, Microbiota and Inflammation in Preclinical Models. Biomolecules, 11.","DOI":"10.3390\/biom11020262"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Shabbir, U., Arshad, M., Sameen, A., and Oh, D.-H. (2021). Crosstalk between Gut and Brain in Alzheimer\u2019s Disease: The Role of Gut Microbiota Modulation Strategies. Nutrients, 13.","DOI":"10.3390\/nu13020690"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Shukla, A.K., Johnson, K., and Giniger, E. (2021). Common features of aging fail to occur in Drosophila raised without a bacterial microbiome. iScience.","DOI":"10.1016\/j.isci.2021.102703"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Borsom, E., Lee, K., and Cope, E. (2020). Do the Bugs in Your Gut Eat Your Memories? Relationship between Gut Microbiota and Alzheimer\u2019s Disease. Brain Sci., 10.","DOI":"10.3390\/brainsci10110814"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-00040-6","article-title":"Intestinal microbial dysbiosis aggravates the progression of Alzheimer\u2019s disease in Drosophila","volume":"8","author":"Wu","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41422-019-0216-x","article-title":"Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer\u2019s disease progression","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Res."},{"key":"ref_155","first-page":"1","article-title":"A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer\u2019s dementia","volume":"13","author":"Xiao","year":"2021","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fnsys.2017.00023","article-title":"Activity-Dependent Synaptic Refinement: New Insights from Drosophila","volume":"11","author":"Vonhoff","year":"2017","journal-title":"Front. Syst. Neurosci."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1007\/s00018-017-2550-9","article-title":"Microbiome, probiotics and neurodegenerative diseases: Deciphering the gut brain axis","volume":"74","author":"Westfall","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Westfall, S., Lomis, N., and Prakash, S. (2019). A novel synbiotic delays Alzheimer\u2019s disease onset via combinatorial gut-brain-axis signaling in Drosophila melanogaster. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0214985"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neurobiolaging.2019.11.004","article-title":"Gut microbiota manipulation through probiotics oral administration restores glucose homeostasis in a mouse model of Alzheimer\u2019s disease","volume":"87","author":"Bonfili","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ebiom.2019.08.032","article-title":"Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer\u2019s disease markers in subjects with mild cognitive impairment","volume":"47","author":"Nagpal","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40142-014-0034-x","article-title":"Late-Onset Alzheimer\u2019s Disease Genes and the Potentially Implicated Pathways","volume":"2","author":"Rosenthal","year":"2014","journal-title":"Curr. Genet. Med. Rep."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3389\/fphar.2020.00537","article-title":"Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation","volume":"11","author":"Shukla","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Lee, S.-H., Gomes, S.M., Ghalayini, J., Iliadi, K.G., and Boulianne, G.L. (2020). Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Rescue Memory Defects in Drosophila-Expressing Alzheimer\u2019s Disease-Related Transgenes Independently of the Canonical Renin Angiotensin System. eNeuro, 7.","DOI":"10.1523\/ENEURO.0235-20.2020"},{"key":"ref_164","first-page":"1844","article-title":"Lisinopril Preserves Physical Resilience and Extends Life Span in a Genotype-Specific Manner in Drosophila melanogaster","volume":"74","author":"Gabrawy","year":"2019","journal-title":"J. Gerontol. Ser. A Boil. Sci. Med Sci."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Ederer, K.A., Jin, K., Bouslog, S., Wang, L., Gorman, G.S., Rowe, G.C., Abadir, P., Raftery, D., Moellering, D., and Promislow, D. (2018). Age- and Genotype-Specific Effects of the Angiotensin-Converting Enzyme Inhibitor Lisinopril on Mitochondrial and Metabolic Parameters in Drosophila melanogaster. Int. J. Mol. Sci., 19.","DOI":"10.20944\/preprints201810.0133.v1"},{"key":"ref_166","first-page":"1","article-title":"Anticancer drugs repurposed for Alzheimer\u2019s disease: A systematic review","volume":"13","author":"Ancidoni","year":"2021","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Ozlu, C., Bailey, R.M., Sinnett, S., and Goodspeed, K.D. (2021). Gene Transfer Therapy for Neurodevelopmental Disorders. Dev. Neurosci., 1\u201311.","DOI":"10.1159\/000515434"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Khan, I., Preeti, K., Fernandes, V., Khatri, D.K., and Singh, S.B. (2021). Role of MicroRNAs, Aptamers in Neuroinflammation and Neurodegenerative Disorders. Cell. Mol. Neurobiol., 1\u201321.","DOI":"10.1007\/s10571-021-01093-4"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40120-020-00218-z","article-title":"CRISPR-Cas9: A Promising Genome Editing Therapeutic Tool for Alzheimer\u2019s Disease\u2014A Narrative Review","volume":"9","author":"Barman","year":"2020","journal-title":"Neurol. Ther."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ddmod.2019.08.004","article-title":"Drosophila and its gut microbes: A model for drug-microbiome interactions","volume":"28","author":"Douglas","year":"2018","journal-title":"Drug Discov. Today Dis. Model."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Ludington, W.B., and Ja, W.W. (2020). Drosophila as a model for the gut microbiome. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008398"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0092-8674(00)00032-5","article-title":"Alzheimer\u2019s Disease: Neurodevelopment Converges with Neurodegeneration","volume":"102","author":"Bothwell","year":"2000","journal-title":"Cell"},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Karisetty, B.C., Bhatnagar, A., Armour, E.M., Beaver, M., Zhang, H., and Elefant, F. (2020). Amyloid-\u03b2 Peptide Impact on Synaptic Function and Neuroepigenetic Gene Control Reveal New Therapeutic Strategies for Alzheimer\u2019s Disease. Front. Mol. Neurosci., 13.","DOI":"10.3389\/fnmol.2020.577622"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fnins.2019.00476","article-title":"Epigenetic Modifications in Alzheimer\u2019s Neuropathology and Therapeutics","volume":"13","author":"Esposito","year":"2019","journal-title":"Front. Neurosci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/13\/7022\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:27:00Z","timestamp":1760164020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/13\/7022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":174,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["ijms22137022"],"URL":"https:\/\/doi.org\/10.3390\/ijms22137022","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,29]]}}}